Interdisciplinary research teams aim to make breakthrough discoveries in basic, translational and clinical cancer research to develop novel anti-cancer treatments.
The microbiome has the potential to revolutionize cancer care by providing treatment alternatives for patients who do previously not respond to cancer (immuno-)therapy. In our project, a prospective interventional fecal microbiota transplantation (FMT) trial and extensive downstream molecular sample analysis will contribute to the understanding of the microbiome-host interactions and enable the identifcation of new targets to be validated and translated into a further refined interventional precision oncology FMT trial.
Metastases of the central nervous system (CNS) are an increasing challenge in oncology because of their increasing prevalence and negative impact on quality of life and survival. The present research network seeks to improve the survival of patients with CNS metastasis by novel profiling approaches of the CNS metastatic tissues and associated host responses and by developing dedicated innovative clinical trials for well-defined subgroups of patients with CNS metastasis.
INTeRCePT: Intercept clonal evolution to overcome treatment resistance in childhood and adult blood cancer
Artificial Intelligence in oncological imaging
Precision Hematology / Oncology